摘要
目的观察炎琥宁与病毒唑治疗小儿急性上呼吸道感染的临床疗效。方法 56例急性上呼吸道感染患儿随机分为两组,观察组(n=28)采用炎琥宁治疗,对照组(n=28)采用病毒唑治疗,两组疗程均为2周,治疗结束后比较两组的疗效。结果观察组治疗总有效率为92.6%,对照组治疗总有效率为78.6%,两组治疗总有效率比较有明显差异性(P<0.05);观察组临床症状和血常规恢复正常时间明显较对照组缩短(P<0.05)。结论炎琥宁治疗小儿急性上呼吸道感染疗效显著,可明显改善患儿的临床症状,值得临床推广应用。
Objective To observe and compare the clinical efficacy of Yanhuning and ribavirin in treatment of children with acute upper respiratory tract infection. Methods 56 children with acute upper respiratory tract infection were randomly divided into two groups. The observation group （ n = 28 ） was treated with Yanhuning and control group （ n = 28 ） was treated with ribavirin. All groups were treated for 2 weeks, and the clinical efficacy of two groups was compared after treatment. Results The total effective rate of observation group was 926%, and the total effective rate of control group was 78.6%. There was a significant difference between the total effective rate of two groups （ P 〈 0. 05 ）. The time of clinical symptoms and blood turn to normal in observation group was significantly shorter than that of the control group （ P 〈 0. 05 ）. Conclusion The treatment of Yanhuning for children with acute upper respiratory tract infection has a sig- nificant efficacy. It can significantly improve the clinical symptoms, and should be worthy of clinical application.
出处
《临床肺科杂志》
2012年第10期1792-1794,共3页
Journal of Clinical Pulmonary Medicine
关键词
炎琥宁
病毒唑
急性上呼吸道感染
~anhuning
Ribavirin
Acute upper respiratory tract infection
